Movement Disorders Clinical Trial
Official title:
Effects of Post Exercise Massage and Cold-water Immersion on Movement Variability and Muscle Stiffness in Swimmers: A Randomized Controlled Clinical Trial
Training prescription is planned considering recovery periods to enhance performance. To assess recovery, a complexity model can be used, in which the main variable would correspond to a fractal of performance. To assess the effectiveness of post-exercise massage and cold-water immersion under a new prism of recovery by means of muscle stiffness and movement variability analysis regarding the sport-specific gesture and an experimental task of shoulder elevation in swimmers.
Status | Not yet recruiting |
Enrollment | 50 |
Est. completion date | September 2023 |
Est. primary completion date | July 2023 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 12 Years to 20 Years |
Eligibility | Inclusion Criteria: - male and female athletes - between 12 and 20 years old - train regularly at swimming teams - no injury over the last month (any complaint that prevented the athlete from training or compete at least once) Exclusion Criteria: - use of pain killers at least 24h before study participation |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Flávia Carvalho |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Coordination pattern | Eleven inertial sensors (XSens) will be positioned on the upper limbs, head and trunk. Data from the sensors will be extracted and processed with non linear analysis to determine the variability of the coordination pattern after fatigue and after interventions | 1 day | |
Secondary | Pain numerical rating scale | Measured by a numerical rating scale ranging from 0 (nothing) to 10 (extreme) before and after the fatiguing protocol and interventions | 1 day | |
Secondary | Perception of Effort | Measured by the modified Borg scale (CR10) ranging from 0 (nothing) to 10 (extremely strong) after the fatiguing protocol and interventions | 1 day | |
Secondary | Recovery | Measured by a numerical rating scale ranging from 0 (nothing) to 10 (extreme) after the fatiguing protocol and interventions | 1 day | |
Secondary | Myotonometry | The MyotonPRO probe will be placed perpendicular to the skin surface on the muscle belly previously marked with a pen by the evaluator at 1: Deltoid; 2: Pectoralis Major; 3: Biceps brachii; 4: Upper Trapezius; 5: Latissimus dorsi; 7: Triceps. Measured before and after the fatiguing protocol and interventions | 1 day | |
Secondary | Skin temperature | The temperature will be measured using an infrared thermographic camera, at the same points of myotonometry. Measured before and after the interventions | 1 day | |
Secondary | Beliefs in the recovery techniques | Participants will be asked if they believe that massage, cold-water immersion and resting contribute to their recovery before and after the study | 1 day | |
Secondary | Preference | After the study the participants will be asked which of the interventions they preferred to received to recover from the fatiguing exercise | 1 day | |
Secondary | Sense of position | Participants will be asked to position their dominant upper limb at 90° which will be indicated by a target fixed on the wall 1 meter ahead of them. They will have 3 chances to point at the target and memorize the position. Afterwards, participants will have 3 chances to point at the target without vision (by blindfold). Measured before and after the fatiguing exercise and interventions | 1 day | |
Secondary | Psychological questionnaire | Participantes should rate physical and mental readiness for the exercise, fatigue, vigor and sleepness from 0 (nothing) to 10 (extreme) | 1 day |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05623644 -
Multimodal MR Imaging Study on ET and PD Patients Subjected With MRgFUS Thalamotomy
|
||
Active, not recruiting |
NCT03548779 -
North Carolina Genomic Evaluation by Next-generation Exome Sequencing, 2
|
N/A | |
Completed |
NCT03295786 -
Clinical Study to Test the Safety of CDNF by Brain Infusion in Patients With Parkinson's Disease
|
Phase 1/Phase 2 | |
Completed |
NCT03722212 -
Early Diagnosis of the GLUT1 Deficiency Syndrome With a Blood Based Test
|
N/A | |
Recruiting |
NCT05973929 -
Movement Disorders in Multiple Sclerosis Patients
|
||
Terminated |
NCT02823158 -
Bilateral Pallidal Stimulation in Patients With Advanced Parkinson's Disease-LATESTIM
|
N/A | |
Enrolling by invitation |
NCT01210781 -
Target Planning for Placement of DBS-electrodes and Follow-up of the Clinical Efficacy of Stimulation
|
||
Enrolling by invitation |
NCT00355927 -
Sedation During Microelectrode Recordings Before Deep Brain Stimulation for Movement Disorders.
|
N/A | |
Completed |
NCT00037167 -
Effects of Exercise Poles on Older Adults During Exercise Walking
|
Phase 1/Phase 2 | |
Recruiting |
NCT04784494 -
MST for Parkinson's Disease
|
N/A | |
Terminated |
NCT03270189 -
Effect of the Visual Information Change in Functional Dystonia
|
N/A | |
Recruiting |
NCT04176692 -
The Effects of Muscle Characteristics on the Control of Shoulder Complex During Functional Movements
|
||
Recruiting |
NCT04061135 -
Neurophysiological, Behavioral, and Cognitive Networks in Movement Disorders
|
N/A | |
Suspended |
NCT04912115 -
Randomized, Double-Blind, Active Placebo-Controlled Study of Ketamine to Treat Levodopa-Induced Dyskinesia
|
Phase 2 | |
Completed |
NCT00500994 -
Neurobiology of Functional Movement Disorder and Non-Epileptic Seizures
|
Early Phase 1 | |
Completed |
NCT04536987 -
Robot Therapy for Rehabilitation of Hand Movement After Stroke
|
Phase 2 | |
Recruiting |
NCT00001208 -
Botulinum Toxin for the Treatment of Involuntary Movement Disorders
|
||
Completed |
NCT02392078 -
Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate System
|
||
Completed |
NCT00552474 -
Deep Brain Stimulation to Treat Symptoms of Parkinson's Disease
|
N/A | |
Not yet recruiting |
NCT05032911 -
Sensorimotor Control in People With and Without Neck Pain
|